Literature DB >> 23419692

The heterogeneous Gleason 7 carcinoma of the prostate: analyses of low and high grade (risk) carcinomas with criteria of the International Society of Urological Pathology (ISUP).

Burkhard Helpap1, Daniel Ringli2, David Adler3, Nicolas Wernert3, Glen Kristiansen3.   

Abstract

Prostate carcinoma (PCa) with Gleason score (GS) 7 has to be examined differentially regarding its prognosis. Using the criteria of ISUP and supplementations, we attempted to analyze the heterogeneity of PCa with GS 7 of biopsy and corresponding specimens of radical prostatectomies (RP). PCa of 530 patients were graded according to Gleason under additional consideration of the state of the nucleoli. Investigating the biopsy specimens, we determined the pattern of Gleason 4 of GS 7, the extension of the tumors in percent, and the number of biopsies containing tumor. In the corresponding specimens of RP, the grading and the state of TNM with margins were assessed. Carcinomas with GS 7 (4+3) in biopsy and RP specimens were unequivocally assigned to the group of high-grade tumors. Carcinomas with GS 7 (3+4) were significantly different from carcinomas with GS 6 when only few and small nucleoli in GS 6 were present (low grade type, p≤0.0001), but were similar to the GS 6 group when nucleoli were prominent (intermediary type, p=0.71). The intermediary group showed an upgrading rate of 36% from GS 6 to GS 7. Furthermore the correlation between organ-confined and non-organ-confined growth showed differences of 63% and 37% in the intermediary group (p=0.0001). The values of grading, staging, margins and metastases indicate that carcinomas of the prostate with the Gleason 3+4 pattern correspond to an intermediary group of carcinomas in contrast to high-grade (high risk) carcinomas with GS 7 and pattern 4+3.
Copyright © 2013 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23419692     DOI: 10.1016/j.prp.2012.10.016

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  4 in total

Review 1.  [Prostate cancer. Part 2: Review of the various tumor grading systems over the years 1966-2015 and future perspectives of the new grading of the International Society of Urological Pathology (ISUP)].

Authors:  B Helpap; L Bubendorf; G Kristiansen
Journal:  Pathologe       Date:  2016-02       Impact factor: 1.011

2.  The Significance of Accurate Determination of Gleason Score for Therapeutic Options and Prognosis of Prostate Cancer.

Authors:  Burkhard Helpap; Daniel Ringli; Jens Tonhauser; Immanuel Poser; Jürgen Breul; Heidrun Gevensleben; Hans-Helge Seifert
Journal:  Pathol Oncol Res       Date:  2015-11-12       Impact factor: 3.201

3.  Expression of Peroxisome Proliferator Activated Receptor gamma in Prostatic Adenocarcinoma.

Authors:  Hyung Kyu Park; HyunKyung Kim; Hyeong-Gon Kim; Young Mee Cho; Woon Yong Jung; Hye Seung Han; Tae Sook Hwang; Ghee Young Kwon; So Dug Lim
Journal:  J Korean Med Sci       Date:  2015-04-15       Impact factor: 2.153

4.  Oncological outcomes in an Australian cohort according to the new prostate cancer grading groupings.

Authors:  K R Beckmann; A D Vincent; M E O'Callaghan; P Cohen; S Chang; M Borg; S M Evans; D M Roder; K L Moretti
Journal:  BMC Cancer       Date:  2017-08-10       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.